Induction of Hepatic Glucose-6-Phosphatase Gene Expression by Lipid Infusion

The distal enzymatic step in the process of glucose output is catalyzed by the glucose-6-phosphatase (Glc-6-Pase) complex. The recently cloned catalytic unit of this complex has been shown to be regulated by insulin, dexamethasone, cAMP, and glucose. Using a combination of intralipid and/or nicotinic acid infusions and a pancreatic clamp technique, we maintained plasma free fatty acids (FFAs) at three different levels (0.26 ± 0.07, 0.56 ± 0.09, and 1.59 ± 0.12 mmol/1) in the presence of well-controlled hormonal and metabolic conditions. An increase in the plasma FFA concentration within the physiological range caused a rapid, greater than threefold increase in the mRNA and protein levels of the catalytic subunit of Glc-6-Pase in the liver. These data indicate that the in vivo gene expression of Glc-6-Pase in the liver is regulated by circulating lipids independent of insulin and thus that prolonged hyperlipidemia may contribute to the increased production of glucose via increased expression of this protein.

[1]  N. Barzilai,et al.  Role of glucokinase and glucose-6-phosphatase in the acute and chronic regulation of hepatic glucose fluxes by insulin. , 1993, The Journal of biological chemistry.

[2]  G. Gil-Gómez,et al.  Peroxisome proliferator-activated receptor mediates induction of the mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase gene by fatty acids. , 1994, The Journal of biological chemistry.

[3]  G. Werve.  Liver glucose-6-phosphatase activity is modulated by physiological intracellular Ca2+ concentrations , 1989 .

[4]  J. Clore,et al.  Sleep-Associated Fall in Glucose Disposal and Hepatic Glucose Output in Normal Humans: Putative Signaling Mechanism Linking Peripheral and Hepatic Events , 1989, Diabetes.

[5]  P. Grimaldi,et al.  Induction of aP2 gene expression by nonmetabolized long-chain fatty acids. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[6]  E. Kraegen,et al.  Development of Muscle Insulin Resistance After Liver Insulin Resistance in High-Fat–Fed Rats , 1991, Diabetes.

[7]  M. Prentki,et al.  A role for malonyl-CoA in glucose-stimulated insulin secretion from clonal pancreatic beta-cells. , 1989, The Journal of biological chemistry.

[8]  R. DeFronzo,et al.  Effect of fatty acids on glucose production and utilization in man. , 1983, The Journal of clinical investigation.

[9]  J. McGarry,et al.  What if Minkowski had been ageusic? An alternative angle on diabetes. , 1992, Science.

[10]  L. Rossetti,et al.  Skeletal muscle glycogenolysis is more sensitive to insulin than is glucose transport/phosphorylation. Relation to the insulin-mediated inhibition of hepatic glucose production. , 1993, The Journal of clinical investigation.

[11]  G. Mithieux,et al.  Characteristics and specificity of the inhibition of liver glucose-6-phosphatase by arachidonic acid. Lesser inhibitability of the enzyme of diabetic rats. , 1993, European journal of biochemistry.

[12]  R. Taub,et al.  High levels of glucose-6-phosphatase gene and protein expression reflect an adaptive response in proliferating liver and diabetes. , 1995, The Journal of clinical investigation.

[13]  G. Mithieux,et al.  Glucose-6-Phosphatase mRNA and Activity Are Increased to the Same Extent in Kidney and Liver of Diabetic Rats , 1996, Diabetes.

[14]  A. Benedetti,et al.  Fatty acyl-CoA esters inhibit glucose-6-phosphatase in rat liver microsomes. , 1995, The Biochemical journal.

[15]  R. A. Srivastava.  Saturated fatty acid, but not cholesterol, regulates apolipoprotein AI gene expression by posttranscriptional mechanism. , 1994, Biochemistry and molecular biology international.

[16]  A. Lange,et al.  Isolation of a cDNA for the catalytic subunit of rat liver glucose-6-phosphatase: regulation of gene expression in FAO hepatoma cells by insulin, dexamethasone and cAMP. , 1994, Biochemical and biophysical research communications.

[17]  G. Mithieux,et al.  Mechanisms by which fatty-acyl-CoA esters inhibit or activate glucose-6-phosphatase in intact and detergent-treated rat liver microsomes. , 1996, European journal of biochemistry.

[18]  H. Shamoon,et al.  Increased lipid oxidation but normal muscle glycogen response to epinephrine in humans with IDDM. , 1996, The American journal of physiology.

[19]  M. Stoffel,et al.  Evolution of β-Cell Dysfunction in the Male Zucker Diabetic Fatty Rat , 1995, Diabetes.

[20]  L. Rossetti,et al.  Relative contribution of glycogen synthesis and glycolysis to insulin-mediated glucose uptake. A dose-response euglycemic clamp study in normal and diabetic rats. , 1990, The Journal of clinical investigation.

[21]  K. Tokuyama,et al.  Effect of high-fat diet on the gene expression of pancreatic GLUT2 and glucokinase in rats. , 1995, Biochemical and biophysical research communications.

[22]  R. Coleman,et al.  2-Bromopalmitoyl-CoA and 2-bromopalmitate: promiscuous inhibitors of membrane-bound enzymes. , 1992, Biochimica et biophysica acta.

[23]  M. Garg,et al.  A comparison of the influence of diets high in saturated versus unsaturated fatty acids on lipid composition and glucose-6-phosphatase activity of rat liver microsomes. , 1985, Biochemistry international.

[24]  S. Clarke,et al.  Coordinate regulation of glycolytic and lipogenic gene expression by polyunsaturated fatty acids. , 1994, Journal of lipid research.

[25]  R. Parrilla,et al.  Control of hepatic gluconeogenesis: role of fatty acid oxidation. , 1989, Archives of biochemistry and biophysics.

[26]  L. Groop,et al.  Contribution of muscle and liver to glucose-fatty acid cycle in humans. , 1993, The American journal of physiology.

[27]  A. Bode,et al.  Recent Advances in Hepatic Glucose 6-Phosphatase Regulation and Function , 1993, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[28]  R. Unger.  Lipotoxicity in the Pathogenesis of Obesity-Dependent NIDDM: Genetic and Clinical Implications , 1995, Diabetes.

[29]  C. Forest,et al.  Fatty acids and fibrates are potent inducers of transcription of the phosphenolpyruvate carboxykinase gene in adipocytes. , 1995, European journal of biochemistry.

[30]  N. Barzilai,et al.  Mechanism by which hyperglycemia inhibits hepatic glucose production in conscious rats. Implications for the pathophysiology of fasting hyperglycemia in diabetes. , 1993, The Journal of clinical investigation.

[31]  N. Barzilai,et al.  Glucose Regulates in Vivo Glucose-6-phosphatase Gene Expression in the Liver of Diabetic Rats (*) , 1996, The Journal of Biological Chemistry.

[32]  L. Rossetti,et al.  Mechanisms of fatty acid-induced inhibition of glucose uptake. , 1994, The Journal of clinical investigation.

[33]  E. Newsholme,et al.  The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. , 1963, Lancet.

[34]  L. Rossetti,et al.  Hyperglycemia Markedly Enhances Skeletal Muscle Glycogen Synthase Activity in Diabetic, But Not in Normal Conscious Rats , 1992, Diabetes.

[35]  B. Landau,et al.  Glucose-6-phosphatase activity in islets from ob/ob and lean mice and the effect of dexamethasone. , 1995, Endocrinology.

[36]  R. DeFronzo,et al.  Correction of hyperglycemia with phlorizin normalizes tissue sensitivity to insulin in diabetic rats. , 1987, The Journal of clinical investigation.

[37]  J. Clore,et al.  Loss of hepatic autoregulation after carbohydrate overfeeding in normal man. , 1995, The Journal of clinical investigation.

[38]  J. Girard,et al.  Cyclic AMP and fatty acids increase carnitine palmitoyltransferase I gene transcription in cultured fetal rat hepatocytes. , 1996, European journal of biochemistry.

[39]  E. Barrett,et al.  Effect of acute diabetes on rat hepatic glucose-6-phosphatase activity and its messenger RNA level. , 1994, Biochemical and biophysical research communications.

[40]  R. Rosebrough,et al.  The effect of non-protein energy sources on the ability of the chick to synthesize glucose-6-phosphatase. , 1976, Poultry science.

[41]  Yii-Der I. Chen,et al.  Measurement of Plasma Glucose, Free Fatty Acid, Lactate, and Insulin for 24 h in Patients With NIDDM , 1988, Diabetes.